# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Novo Integrated Sciences (NASDAQ:NVOS) reported quarterly losses of $(0.16) per share. This is a 72.88 percent increase over lo...
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collabo...
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and Clinical Consultants International,...
The Waiver Exempts any determination of non-compliance associated to Nasdaq's Minimum Bid Price Requirement Rule
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo") announces today Mr. Robert Oliva has be...